While CD24 was first identified as a valuable marker for cellular development and differentiation, accumulating studies have revealed critical roles for CD24 in various pathological conditions, including autoimmune diseases (4–8), sepsis (9), metabolic disorders (10–12), graft vs host diseases (13, 14) and cancer (1, 15–20). This evidence concerns the gene CD24 and cancer.